Nasopharyngeal carcinoma in Slovenia, 1990-2003 (results of treatment with conventional two-dimensional radiotherapy)

Reports of Practical Oncology and Radiotherapy

Volumn 17, Issue 2, 2012, Pages 71-78

  Čarman, Janka ^a   Strojan, Primož ^a  

^a INSTITUTE OF ONCOLOGY   (Slovenia)

Author keywords

Chemotherapy; Nasopharyngeal carcinoma; Prognostic factors; Radiotherapy; Survival

Indexed keywords

BLEOMYCIN; CARBOPLATIN; CISPLATIN; FLUOROURACIL; MITOMYCIN C;

ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER REGISTRY; CANCER SURGERY; CANCER SURVIVAL; CONVENTIONAL TWO DIMENSIONAL RADIOTHERAPY; DATA BASE; DISEASE CONTROL; DISEASE FREE SURVIVAL; DISEASE SPECIFIC SURVIVAL; DISTANT FAILURE FREE SURVIVAL; FEMALE; FOLLOW UP; GROUPS BY AGE; HISTOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; NASOPHARYNX CARCINOMA; OVERALL SURVIVAL; PROGNOSIS; SLOVENIA;

EID: 84859722874     PISSN: 15071367     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rpor.2012.01.002     Document Type: Article

References (27)

1. Hu K.S., Chan A.T.C., Costantino P., Harrison L.B. Cancer of the nasopharynx. Head and neck cancer: a multidisciplinary approach 2009, 502-529. Williams & Wilkins/Wolters Kluwer, Lippincott/Philadelphia. 3rd ed. L.B. Harrison, R.B. Sessions, W.K. Hong (Eds.).
2. Cancer Registry of Slovenia. Cancer in Slovenia 1990-2003. Reports no. 32-45. Ljubljana: Institute of Oncology & Cancer Registry of Republic of Slovenia; 1993-2006.
3. Chan A.T.C., Felip E. Nasopharyngeal cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol 2009, 20(Suppl. 4):iv123-iv125. on behalf of the ESMO guidelines working group.
4. Chan J.K.C., Bray F., McCarron P., et al. Nasopharyngeal carcinoma. Pathology and genetics of head and neck tumors 2005, 81-97. IARC Press, Lyon. L. Barnes, J.W. Eveson, P. Reichart, D. Sidransky (Eds.).
5. TNM classification of malignant tumours 2002, 27-33. Wiley Liss, New York. 6th ed. L.H. Sobin, C. Wittekind (Eds.).
6. Bentzen S.M., Baumann M. The linear-quadratic model in clinical practice. Basic clinical radiobiology 2002, 134-146. Arnold, London. 3rd ed. G.G. Steel (Ed.).
7. Kaplan E.L., Meir P. Nonparametric estimation from incomplete observation. J Am Stat Assoc 1958, 53:457-481.
8. Peto R., Pike M.C., Armitage P., et al. Design and analysis of randomized clinical trials requiring prolong observation of each patient. II. Analysis and examples. Br J Cancer 1977, 35:1-39.
9. Cox D.R. Regression models and life tables. J R Stat Soc 1972, 187:187-220.
10. Sanguineti G., Geara F.B., Garden A.S., et al. Carcinoma of the nasopharynx treated by radiotherapy alone: determinants of local and regional control. Int J Radiat Oncol Biol Phys 1997, 37:985-996.
11. Yeh S.A., Tang Y., Lui C.C., Huang Y.J., Huang E.Y. Treatment outcomes and late complications of 849 patients with nasopharyngeal carcinoma treated with radiotherapy alone. Int J Radiat Oncol Biol Phys 2005, 62:672-679.
12. Yi J.L., Gao L., Huang X.D., et al. Nasopharyngeal carcinoma treated by radical radiotherapy alone: ten-year experience of a single institution. Int J Radiat Oncol Biol Phys 2006, 65:161-168.
13. Heng D.M.K., Wee J., Fong K.-W., et al. Prognostic factors in 677 patients in Singapore with nondisseminated nasopharyngeal carcinoma. Cancer 1999, 86:1912-1920.
14. Lee A.W.M., Sze W.M., Au J.S.K., et al. Treatment results for nasopharyngeal carcinoma in the modern era: the Hong Kong experience. Int J Radiat Oncol Biol Phys 2005, 61:1107-1116.
15. Hoppe R.T., Goffinet D.R., Bagshaw M.A. Carcinoma of the nasopharynx. Eighteen years' experience with megavoltage radiation therapy. Cancer 1976, 37:2605-2612.
16. Lai S.-Z., Li W.-F., Chen L., et al. How does intensity-modulated radiotherapy versus conventional two-dimensional radiotherapy influence the treatment results in nasopharyngeal carcinoma patients?. Int J Radiat Oncol Biol Phys 2011, 80:661-668.
17. Hara W., Loo B.W., Goffinet D.R., et al. Excellent local control with stereotactic radiotherapy boost after external beam radiotherapy in patients with nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 2008, 71:393-400.
18. Schinagl D.A.X., Marres H.A.M., Kappelle A.C., et al. External beam radiotherapy with endocavitary boost for nasopharyngeal cancer: treatment results and late toxicity after extended follow-up. Int J Radiat Oncol Biol Phys 2010, 78:689-695.
19. Al-Sarraf M., LeBlanc M., Giri P.G.S., et al. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099. J Clin Oncol 1998, 16:1310-1317.
20. Palazzi M., Guzzo M., Tomatis S., et al. Improved outcome of nasopharyngeal carcinoma treated with conventional radiotherapy. Int J Radiat Oncol Biol Phys 2004, 60:1451-1458.
21. Baujat B., Audry H., Bourhis J., et al. Chemotherapy in locally advanced nasopharyngeal carcinoma: an individual patient data meta-analysis of eight randomized trials and 1753 patients. Int J Radiat Oncol Biol Phys 2006, 64:47-56.
22. Liao X.-B., Mao Y.-P., Liu L.-Z., et al. How does magnetic resonance imaging influence staging according to AJCC staging system for nasopharyngeal carcinoma compared with computed tomography. Int J Radiat Oncol Biol Phys 2008, 72:1368-1377.
23. Trojanowska A. Squamous cell carcinoma of the head and neck - the role of diffusion and perfusion imaging in tumor recurrence and follow up. Rep Pract Oncol Radiother 2011, 16:203-208.
24. Palazzi M., Orlandi E., Bossi P., et al. Further improvement in outcomes of nasopharyngeal carcinoma with optimized radiotherapy and induction plus concomitant chemotherapy: an update of the Milan experience. Int J Radiat Oncol Biol Phys 2009, 74:774-780.
25. Bindhu J., Supe S., Pawar Y. Intensity modulated radiotherapy (IMRT) the white, black and gray: a clinical perspective. Rep Pract Oncol Radiother 2009, 14:95-103.
26. Joseph B., Supe S.S., Ramachandra A. Cyberknife: a double edged sword?. Rep Pract Oncol Radiother 2010, 15:93-97.
27. Zhang L., Zhao C., Ghimire B., et al. The role of concurrent chemoradiotherapy in the treatment of locoregionally advanced nasopharyngeal carcinoma among endemic population: a meta-analysis of the phase III randomized trials. BMC Cancer 2010, 10:558.